DM

Deerfield Management Portfolio holdings

AUM $5.51B
This Quarter Return
-7.48%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.45B
AUM Growth
+$2.45B
Cap. Flow
-$57.8M
Cap. Flow %
-2.36%
Top 10 Hldgs %
44.05%
Holding
113
New
16
Increased
20
Reduced
24
Closed
16

Top Buys

1
RYTM icon
Rhythm Pharmaceuticals
RYTM
$42.4M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
$34.7M
3
AERI
Aerie Pharmaceuticals, Inc.
AERI
$29.5M
4
SWTX
SpringWorks Therapeutics
SWTX
$22.8M
5
CNC icon
Centene
CNC
$18.1M

Top Sells

1
NTRA icon
Natera
NTRA
$27.7M
2
STAA icon
STAAR Surgical
STAA
$25.8M
3
NVRO
NEVRO CORP.
NVRO
$25M
4
IMMU
Immunomedics Inc
IMMU
$23.5M
5
NVTA
Invitae Corporation
NVTA
$23.4M

Sector Composition

1 Healthcare 71.32%
2 Financials 0.3%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TNDM icon
26
Tandem Diabetes Care
TNDM
$834M
$26.8M 1.09%
454,334
+301,834
+198% +$17.8M
EDIT icon
27
Editas Medicine
EDIT
$225M
$26.4M 1.07%
1,158,841
– –
DFBHU
28
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
$25.8M 1.05%
2,500,000
– –
AXGN icon
29
Axogen
AXGN
$718M
$23M 0.94%
1,842,330
+951,024
+107% +$11.9M
SWTX
30
DELISTED
SpringWorks Therapeutics
SWTX
$22.8M 0.93%
+1,050,888
New +$22.8M
XERS icon
31
Xeris Biopharma Holdings
XERS
$1.27B
$22.7M 0.93%
2,308,666
-71,235
-3% -$700K
MOH icon
32
Molina Healthcare
MOH
$9.6B
$21.6M 0.88%
197,056
+47,056
+31% +$5.16M
RCKT icon
33
Rocket Pharmaceuticals
RCKT
$358M
$20.7M 0.84%
1,773,938
+636,796
+56% +$7.42M
DCPH
34
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$20.2M 0.82%
594,725
-12,908
-2% -$438K
ADUS icon
35
Addus HomeCare
ADUS
$2.08B
$20.1M 0.82%
252,915
– –
ARVN icon
36
Arvinas
ARVN
$580M
$19.9M 0.81%
921,234
– –
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$18.2M 0.74%
233,000
-31,600
-12% -$2.46M
HUM icon
38
Humana
HUM
$37.5B
$17.1M 0.7%
67,000
– –
WVE icon
39
Wave Life Sciences
WVE
$1.27B
$16.6M 0.68%
807,727
+138,467
+21% +$2.84M
ARDX icon
40
Ardelyx
ARDX
$1.57B
$16M 0.65%
3,400,410
-60,888
-2% -$286K
PTCT icon
41
PTC Therapeutics
PTCT
$4.41B
$15.9M 0.65%
471,000
– –
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$15.8M 0.64%
197,000
– –
GLPG icon
43
Galapagos
GLPG
$2.06B
$15.4M 0.63%
101,010
– –
ANAB icon
44
AnaptysBio
ANAB
$630M
$14.9M 0.61%
425,443
-115,086
-21% -$4.03M
DPLO
45
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$14.7M 0.6%
2,996,328
-4,040,342
-57% -$19.8M
TPTX
46
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$14.6M 0.59%
387,545
+100,000
+35% +$3.76M
BOLD
47
DELISTED
Audentes Therapeutics, Inc
BOLD
$13.9M 0.57%
493,901
– –
SYRS
48
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$13.2M 0.54%
126,895
– –
GBT
49
DELISTED
Global Blood Therapeutics, Inc.
GBT
$13M 0.53%
268,100
+33,100
+14% +$1.61M
AVDL
50
Avadel Pharmaceuticals
AVDL
$1.45B
$11.3M 0.46%
2,722,241
– –
1
2
3 4 5